Clinical Trial Update: Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether GLP-1 treatment reduces alcohol intake in patients with alcohol dependence (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Addiction
• Alcohol Dependence

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Anders Fink-Jensen, MD, DMSci | Conditions: Alcohol Dependence, in Remission, Addiction, Alcohol | Phase 2 | Status: COMPLETED